Inducible high-level expression vector for mammalian cells, pEF-LAC carrying human elongation factor 1alpha promoter

¹Faculty of Bioscience and Biotechnology, Tokyo Institute of Technology, Midori-ku, Yokohama, Japan.

|March 18, 1997

Abstract:

We have constructed an inducible high-level expression vector, pEF-LAC. pEF-LAC has a modified human polypeptide chain elongation factor 1alpha (EF-1alpha) promoter containing three lactose operator sequences. Using the cat reporter gene, we characterized the transcriptional activity of pEF-LAC. In the transient transfection of NIH3T3 and BaF3 cells, the transcriptional activity of pEF-LAC was higher than that of the original human elongation factor 1alpha promoter, simian virus 40 (SV40) promoter, and Rous sarcoma virus (RSV) long terminal repeat (LTR). Cotransfection of the lactose repressor expression plasmid effectively suppressed the promoter activity of pEF-LAC, and the activity was fully recovered by addition of isopropyl beta-D-thiogalactopyranoside (IPTG). Even in the stable transfection of Rat-1 cells, the promoter activity of the integrated pEF-LAC was much higher than that of the RSV-LTR and regulated in an IPTG-dependent manner. These results suggest that pEF-LAC is a useful vector for the inducible high-level expression of the cloned gene in a variety of mammalian cells.

Related Experiment Videos

Inducible high-level expression vector for mammalian cells, pEF-LAC carrying human elongation factor 1alpha promoter

Related Concept Videos

Protein farnesylation in mammalian cells: effects of farnesyltransferase inhibitors on cancer cells.

Potentiation of nitric oxide-induced apoptosis of MDA-MB-468 cells by farnesyltransferase inhibitor: implications in breast cancer.

Changes in permeability of strial vessels following vibration given to auditory ossicle by drill.

LUCA15, a putative tumour suppressor gene encoding an RNA-binding nuclear protein, is down-regulated in ras-transformed Rat-1 cells.

Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell lines.

Expression of an oncogenic mutant G alpha i2 activates Ras in Rat-1 fibroblast cells.

Dormancy and reactivation of disseminated tumor cells: From molecular mechanisms to therapeutic implications.

An Association study of the SOD2 rs4880 (Ala16Val) Variant with Autism Spectrum Disorder.

ERO1A is a hypoxia-ER bridge in NSCLC: from pan-cancer identification to a dual-reporter visualization system.

Decreased expression of Krüppel-like factor 4 is associated with colorectal cancer progression.

Multifaceted signaling of the cell surface receptor neuropilin-1 (NRP1): pathophysiological roles and therapeutic potential.

Alternative splicing in Alzheimer's disease: event-level evidence, risk-locus biology, and RNA-based therapeutic perspectives.

High-performance AIECL immunosensor based on V-TCPE metal-organic frameworks and CoMoO4@Au nanoflowers as co-reaction accelerator for ultrasensitive detection of T-2 toxin.

UiO-67 modified screen-printed carbon electrodes for selective electrochemical determination of tyrosine in complex biological matrices.

Breaking Charge Symmetry in Co-Zn Dual‑Atom Catalyst With Axial Sulfur Coordination for Efficient Oxygen Reduction Reaction.

Natural deep eutectic solvents as plasticizers for advancing sustainable strain sensors.

Chlorin e6-loaded ethosomes for photodynamic wound therapy.

Conversion of a ventricular rickham reservoir to a subcutaneous chest port for repeated intraventricular enzyme replacement therapy: technical note and surgical considerations.

Related Experiment Videos

Inducible high-level expression vector for mammalian cells, pEF-LAC carrying human elongation factor 1alpha promoter...

Abstract:

Related Concept Videos

Related Articles

Inducible high-level expression vector for mammalian cells, pEF-LAC carrying human elongation factor 1alpha promoter